BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20167695)

  • 1. Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.
    Marchei E; Farré M; Pardo R; Garcia-Algar O; Pellegrini M; Pacifici R; Pichini S
    Clin Chem; 2010 Apr; 56(4):585-92. PubMed ID: 20167695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.
    Marchei E; Farrè M; Pellegrini M; García-Algar O; Vall O; Pacifici R; Pichini S
    Forensic Sci Int; 2010 Mar; 196(1-3):59-63. PubMed ID: 20096514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.
    Arvidsson M; Dahl ML; Beck O; Ackehed G; Nordin K; Rosenborg S
    Eur J Clin Pharmacol; 2020 Feb; 76(2):229-237. PubMed ID: 31786618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study.
    Marchei E; Farré M; Pardo R; Garcia-Algar O; Pellegrini M; Pacifici R; Pichini S
    Ther Drug Monit; 2010 Aug; 32(4):508-11. PubMed ID: 20535053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man.
    Tuerck D; Wang Y; Maboudian M; Wang Y; Sedek G; Pommier F; Appel-Dingemanse S
    Int J Clin Pharmacol Ther; 2007 Dec; 45(12):662-8. PubMed ID: 18184535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography-electrospray ionization mass spectrometry determination of methylphenidate and ritalinic acid in conventional and non-conventional biological matrices.
    Marchei E; Farrè M; Pellegrini M; Rossi S; García-Algar O; Vall O; Pichini S
    J Pharm Biomed Anal; 2009 Feb; 49(2):434-9. PubMed ID: 19117711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an UFLC-MS/MS method for enantioselectivity determination of d,l-thero-methylphenidate, d,l-thero-ethylphenidate and d,l-thero-ritalinic acid in rat plasma and its application to pharmacokinetic study.
    Zhang C; Luo H; Wu Y; Zhang J; Zhang F; Lin G; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():45-52. PubMed ID: 26751592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput selected reaction monitoring liquid chromatography-mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns.
    Barbarin N; Mawhinney DB; Black R; Henion J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):73-83. PubMed ID: 12450526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults.
    Childress A; Stark JG; McMahen R; Engelking D; Sikes C
    Clin Pharmacol Drug Dev; 2018 Feb; 7(2):151-159. PubMed ID: 28544581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual and Intraindividual Variation of Methylphenidate Concentrations in Serum and Saliva of Patients With Attention-Deficit/Hyperactivity Disorder.
    Preiskorn J; Studer S; Rauh R; Lukačin R; Geffert C; Fleischhaker C; Clement HW; Schulz E; Biscaldi M
    Ther Drug Monit; 2018 Aug; 40(4):435-442. PubMed ID: 29750737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of methylphenidate and ritalinic acid in blood, plasma and oral fluid from adolescents and adults using protein precipitation and liquid chromatography tandem mass spectrometry--a method applied on clinical and forensic investigations.
    Josefsson M; Rydberg I
    J Pharm Biomed Anal; 2011 Jul; 55(5):1050-9. PubMed ID: 21497039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid quantitative analysis of methylphenidate and ritalinic acid in oral fluid by liquid chromatography triple quadrupole mass spectrometry (LC-QqQ-MS).
    Mulet CT; Arroyo-Mora LE; Leon LA; Gnagy E; DeCaprio AP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():313-319. PubMed ID: 29935479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LC-MS/MS assay of methylphenidate: stability and pharmacokinetics in human].
    Luo XM; Ding L; Gu X; Jiang LY; Dong X
    Yao Xue Xue Bao; 2014 Jan; 49(1):83-8. PubMed ID: 24783511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of methylphenidate in man, rat and monkey.
    Wargin W; Patrick K; Kilts C; Gualtieri CT; Ellington K; Mueller RA; Kraemer G; Breese GR
    J Pharmacol Exp Ther; 1983 Aug; 226(2):382-6. PubMed ID: 6410043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans.
    Srinivas NR; Hubbard JW; Korchinski ED; Midha KK
    Pharm Res; 1993 Jan; 10(1):14-21. PubMed ID: 8430051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC determination of methylphenidate and its metabolite, ritalinic acid, by high-performance liquid chromatography with peroxyoxalate chemiluminescence detection.
    Wada M; Abe K; Ikeda R; Kikura-Hanajiri R; Kuroda N; Nakashima K
    Anal Bioanal Chem; 2011 Apr; 400(2):387-93. PubMed ID: 21318251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of methylphenidate and ritalinic acid in hair using LC-MS/MS.
    Jang M; Kim J; Shin I; Kang S; Choi H; Yang W
    Forensic Sci Int; 2019 Jan; 294():183-188. PubMed ID: 30530155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.